"We envision an entirely different approach to treating solid human tumors of numerous pathologic subtypes, including common metastatic malignancies such as breast, melanoma, colon, prostate, and lung, utilizing these capsules as a delivery platform," explained senior study investigator Eugenia Kharlampieva, Ph.D., associate professor in the department of chemistry at the UAB College of Arts and Sciences.